Lower bone mineral density in children with type 1 diabetes is associated with poor glycemic control and higher serum ICAM-1 and urinary isoprostane levels

[1]  V. Tillmann,et al.  Arterial stiffness, carotid artery intima-media thickness and plasma myeloperoxidase level in children with type 1 diabetes. , 2009, Diabetes research and clinical practice.

[2]  J. Manson,et al.  Inflammation and Progressive Nephropathy in Type 1 Diabetes in the Diabetes Control and Complications Trial , 2008, Diabetes Care.

[3]  L. McCabe.  Understanding the pathology and mechanisms of type I diabetic bone loss , 2007, Journal of cellular biochemistry.

[4]  T. Rohrer,et al.  Delayed pubertal onset and development in German children and adolescents with type 1 diabetes: cross-sectional analysis of recent data from the DPV diabetes documentation and quality management system. , 2007, European journal of endocrinology.

[5]  F. Demirel,et al.  Role of hemoglobin A1c, duration and puberty on bone mineral density in diabetic children , 2007, Pediatrics international : official journal of the Japan Pediatric Society.

[6]  R. Kitazawa,et al.  Histomorphometric analysis of diabetic osteopenia in streptozotocin-induced diabetic mice: a possible role of oxidative stress. , 2007, Bone.

[7]  Robert A. Smith,et al.  Hydrogen peroxide mediates damage by xanthine and xanthine oxidase in cerebellar granule neuronal cultures , 2007, Neuroscience Letters.

[8]  P. Vestergaard,et al.  Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis , 2007, Osteoporosis International.

[9]  G. Sebag,et al.  Lower bone mineral content in children with type 1 diabetes mellitus is linked to female sex, low insulin-like growth factor type I levels, and high insulin requirement. , 2006, The Journal of clinical endocrinology and metabolism.

[10]  Ta-Liang Chen,et al.  2,6‐Diisopropylphenol Protects Osteoblasts from Oxidative Stress‐Induced Apoptosis through Suppression of Caspase‐3 Activation , 2005, Annals of the New York Academy of Sciences.

[11]  L. Moyer-Mileur,et al.  Bone mineral acquisition in adolescents with type 1 diabetes. , 2004, The Journal of pediatrics.

[12]  J. Clària,et al.  F2 isoprostane is already increased at the onset of type 1 diabetes mellitus: effect of glycemic control. , 2004, Metabolism: clinical and experimental.

[13]  A. Salvatoni,et al.  Bone mineral density in diabetic children and adolescents: a follow-up study. , 2004, Bone.

[14]  Hang Zheng,et al.  Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB. , 2004, Biochemical and biophysical research communications.

[15]  J. Dmochowski,et al.  Does low bone mineral density start in post-teenage years in women with type 1 diabetes? , 2003, Diabetes care.

[16]  F. Santilli,et al.  Enhanced Lipid Peroxidation and Platelet Activation in the Early Phase of Type 1 Diabetes Mellitus: Role of Interleukin-6 and Disease Duration , 2003, Circulation.

[17]  V. Tillmann,et al.  Male Sex and Low Physical Activity Are Associated With Reduced Spine Bone Mineral Density in Survivors of Childhood Acute Lymphoblastic Leukemia , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  K. Michaëlsson,et al.  Association between oxidative stress and bone mineral density. , 2001, Biochemical and biophysical research communications.

[19]  F. Parhami,et al.  Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. , 2001, Free radical biology & medicine.

[20]  M. Brownlee,et al.  Negative consequences of glycation. , 2000, Metabolism: clinical and experimental.

[21]  P. Bollen,et al.  Lumbar Spine Bone Mineral Density in Diabetic Children with Recent Onset , 1998, Hormone Research in Paediatrics.

[22]  Wd Evans,et al.  Measured and predicted bone mineral content in healthy boys and girls aged 6–18 years: adjustment for body size and puberty , 1998, Acta paediatrica.

[23]  J. Morrow,et al.  The isoprostanes. Current knowledge and directions for future research. , 1996, Biochemical pharmacology.

[24]  V. Tillmann,et al.  Physical Development in Estonian Children with Type 1 Diabetes , 1996, Diabetic medicine : a journal of the British Diabetic Association.

[25]  G. FitzGerald,et al.  Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man. , 1995, The Journal of pharmacology and experimental therapeutics.

[26]  H. Kröger,et al.  Comparison of different models for interpreting bone mineral density measurements using DXA and MRI technology. , 1995, Bone.

[27]  D. Rao,et al.  Bone Loss and Bone Turnover in Diabetes , 1995, Diabetes.

[28]  R. Heaney,et al.  Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model. , 1994, The Journal of clinical investigation.

[29]  J. Morrow,et al.  Identification of non-cyclooxygenase-derived prostanoid (F2-isoprostane) metabolites in human urine and plasma. , 1993, The Journal of biological chemistry.

[30]  R. Shephard,et al.  A simple method to assess exercise behavior in the community. , 1969, Canadian journal of applied sport sciences. Journal canadien des sciences appliquees au sport.

[31]  L. Moyer-Mileur,et al.  Alterations in bone characteristics associated with glycemic control in adolescents with type 1 diabetes mellitus. , 2004, The Journal of pediatrics.

[32]  B Kirchhof,et al.  Leukocyte-mediated endothelial cell injury and death in the diabetic retina. , 2001, The American journal of pathology.

[33]  M. Paoli,et al.  Decreased Bone Mineral Density and Bone Formation Markers Shortly After Diagnosis of Clinical Type 1 Diabetes Mellitus , 2001, Journal of pediatric endocrinology & metabolism : JPEM.

[34]  J. Argente,et al.  Bone Mineral Density in Children and Adolescents with Diabetes Mellitus Type 1 of Recent Onset , 1998, Calcified Tissue International.

[35]  H Keen,et al.  The Diabetes Control and Complications Trial (DCCT). , 1994, Health trends.